344 related articles for article (PubMed ID: 28408855)
1. Targeted therapy for soft tissue sarcomas in adolescents and young adults.
Steppan DA; Pratilas CA; Loeb DM
Adolesc Health Med Ther; 2017; 8():41-55. PubMed ID: 28408855
[TBL] [Abstract][Full Text] [Related]
2. Canine Soft Tissue Sarcomas: Can Being a Dog's Best Friend Help a Child?
Séguin B
Front Oncol; 2017; 7():285. PubMed ID: 29218302
[TBL] [Abstract][Full Text] [Related]
3. Novel Insights into the Immunotherapy of Soft Tissue Sarcomas: Do We Need a Change of Perspective?
Ozaniak A; Vachtenheim J; Lischke R; Bartunkova J; Strizova Z
Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440139
[TBL] [Abstract][Full Text] [Related]
4. [Histology-Specific Chemotherapy in Soft-Tissue Sarcomas].
Kobayashi E; Kawai A
Gan To Kagaku Ryoho; 2017 Jun; 44(6):468-472. PubMed ID: 28698435
[TBL] [Abstract][Full Text] [Related]
5. The pathologic response of resected synovial sarcomas to hyperthermic isolated limb perfusion with melphalan and TNF-α: a comparison with the whole group of resected soft tissue sarcomas.
Schwindenhammer B; Podleska LE; Kutritz A; Bauer S; Sheu SY; Taeger G; Schmid KW; Grabellus F
World J Surg Oncol; 2013 Aug; 11(1):185. PubMed ID: 23938063
[TBL] [Abstract][Full Text] [Related]
6. Current classification, treatment options, and new perspectives in the management of adipocytic sarcomas.
De Vita A; Mercatali L; Recine F; Pieri F; Riva N; Bongiovanni A; Liverani C; Spadazzi C; Miserocchi G; Amadori D; Ibrahim T
Onco Targets Ther; 2016; 9():6233-6246. PubMed ID: 27785071
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapeutic drugs for soft tissue sarcomas: a review.
Tian Z; Yao W
Front Pharmacol; 2023; 14():1199292. PubMed ID: 37637411
[TBL] [Abstract][Full Text] [Related]
8. Nanomaterial Technology and Soft Tissue Sarcomas.
Zhou C; Chen X; Huang Y; Zhang Q; Zhu S; Fu W
Front Oncol; 2022; 12():921983. PubMed ID: 35814363
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy for high-risk soft tissue sarcoma in the adult.
Gronchi A; Casali PG
Curr Treat Options Oncol; 2013 Sep; 14(3):415-24. PubMed ID: 23775297
[TBL] [Abstract][Full Text] [Related]
10. Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention.
Tazzari M; Bergamaschi L; De Vita A; Collini P; Barisella M; Bertolotti A; Ibrahim T; Pasquali S; Castelli C; Vallacchi V
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299136
[TBL] [Abstract][Full Text] [Related]
11. Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review.
Roulleaux Dugage M; Nassif EF; Italiano A; Bahleda R
Front Immunol; 2021; 12():775761. PubMed ID: 34925348
[TBL] [Abstract][Full Text] [Related]
12. Current stand on systemic therapy in localized soft tissue sarcomas: a clinician's perspective.
Sasi A; Rastogi S
Future Oncol; 2023 Oct; 19(31):2135-2145. PubMed ID: 37860850
[TBL] [Abstract][Full Text] [Related]
13. Analysis of bone and soft-tissue sarcomas registered during the year 2012 at Tata Memorial Hospital, Mumbai, with clinical outcomes.
Bajpai J; Khanna N; Vora T; Gulia A; Laskar S; Puri A; Sanduptla B; Chinnaswamy G; Nayak P; Juvekar SL; Janu A; Desai S; Ghosh J; Purandare N; Ramadwar M; Rangarajan V; Rekhi B
Indian J Cancer; 2018; 55(1):37-44. PubMed ID: 30147091
[TBL] [Abstract][Full Text] [Related]
14. New therapeutic strategies for soft tissue sarcomas.
von Mehren M
Curr Treat Options Oncol; 2003 Dec; 4(6):441-51. PubMed ID: 14585225
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy in soft tissue sarcomas…Conflicts, consensus, and controversies.
Bajpai J; Susan D
South Asian J Cancer; 2016; 5(1):15-9. PubMed ID: 27169114
[TBL] [Abstract][Full Text] [Related]
16. Immune Cells in the Tumor Microenvironment of Soft Tissue Sarcomas.
Jumaniyazova E; Lokhonina A; Dzhalilova D; Kosyreva A; Fatkhudinov T
Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136307
[TBL] [Abstract][Full Text] [Related]
17. Statistics of soft-tissue sarcoma in Japan: Report from the Bone and Soft Tissue Tumor Registry in Japan.
Ogura K; Higashi T; Kawai A
J Orthop Sci; 2017 Jul; 22(4):755-764. PubMed ID: 28601416
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of potential tumor suppressor miR-34b/c is correlated with late clinical stage in patients with soft tissue sarcomas.
Xie Y; Zong P; Wang W; Liu D; Li B; Wang Y; Hu J; Ren Y; Qi Y; Cui X; Chen Y; Liu C; Li F
Exp Mol Pathol; 2015 Jun; 98(3):446-54. PubMed ID: 25773680
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenesis agents in the treatment of soft tissue sarcomas.
Ganjoo K; Jacobs C
Cancer; 2010 Mar; 116(5):1177-83. PubMed ID: 20052715
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
